Search

everythinglearnresearchcommunity

for

Search:↓

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

FFA and FAPD might be related or stages of the same disease.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Avacopan may cause unexpected side effects, so early monitoring is important.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Precise objectives can improve student achievement in health education.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Androgen receptors help prostate cancer cells grow and resist drugs.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Overexpressing AVP1 and AtNHX1 in plants improves salt tolerance and root hair development.

AH-001 could be a safer and more effective treatment for hair loss.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.